018900273

T-CEPTOR

---

July 11, 2023

Trademark Summary

The trademark application T-CEPTOR was filed by T-Therapeutics Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 30, 2023, and it was registered by office on December 7, 2023 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on March 28, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations
  2. Pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes
  3. Chemical preparations for use in DNA analysis [medical]
  4. DNA synthesis inhibitors
  5. Biological preparations for the treatment of cancer
  6. Biological preparations for the treatment of viral infections
  7. Biological preparations for the treatment of autoimmune diseases
  8. Biological preparations for medical use
  9. Immunotherapeutic drugs
  10. Reagents for medical use
  11. Diagnostic preparations
  12. Diagnostic reagents for medical use
  13. Preparations for detecting genetic predispositions for medical purposes.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific and technological services and research and design relating thereto
  2. Medical research and design relating thereto
  3. Industrial analysis and industrial research services
  4. Research in the field of DNA repair technology
  5. Design and development of computer hardware and software
  6. Genetic microbiology and microbiome research
  7. Genetic engineering and services
  8. Design and development of hardware and software
  9. Clinical research
  10. Clinical trials
  11. Pharmaceutical research and development
  12. Development of pharmaceutical preparations and medicines
  13. Research and development services in the field of antibiotics
  14. Research and development of guided nuclease-based biocides
  15. Conducting clinical trials for pharmaceutical products
  16. Bacteriological research
  17. Viral research
  18. Biological research
  19. Scientific screening and assaying
  20. Chemical analysis
  21. Chemical research
  22. DNA screening for scientific research purposes
  23. Genetic testing of laboratory animals for research purposes
  24. Biochemical engineering services
  25. Providing information about the results of clinical trials for pharmaceutical products
  26. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  27. Provision of advice, information and consultancy in relation to the aforesaid services.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical services and provision of advice, information and consultancy in relation to the aforesaid services
  2. Diagnostic and prognostic medical services
  3. Veterinary services
  4. Medical analysis services relating to the treatment of persons
  5. Pharmacy advice
  6. Medical and health services relating to DNA, genetics, and genetic pathogen testing
  7. Medical screening and assaying
  8. DNA screening for medical purposes.